Asie · Bourse & Finance · SCMP Business

Hong Kong needs new funding model to draw investment from global drug makers: AstraZeneca

Publié par SCMP Business · Hong Kong il y a 2 h

Hong Kong can attract more global biotech investments if the city builds up a new healthcare financial model, according to AstraZeneca, a Cambridge-based multinational…

Lire l'article complet sur SCMP Business Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.scmp.com)

Hong Kong needs new funding model to draw investment from global drug makers: AstraZeneca

À lire aussi

Younger researchers studying pressing labour issues get more support from NTUC

Capital SFB Q2 Update: Deposits rise 16%, advances up 23%; Gross NPA improves

Gold price future roadmap: Why led to 6% yellow metal fall in Sept 2026? Will Diwali help bounce back? Experts view

At 52-week lows: RIL, ONGC, M&M, Airtel, PB Fintech, 69 other BSE500 stocks

Jacqueline Loh to step down as MAS deputy MD in senior leadership reshuffle

ShopeePay CEO on BNPL: why relying on late fees will fail

Hong Kong needs new funding model to draw investment from global drug makers: AstraZeneca

Partager

À lire aussi

Younger researchers studying pressing labour issues get more support from NTUC

Capital SFB Q2 Update: Deposits rise 16%, advances up 23%; Gross NPA improves

Gold price future roadmap: Why led to 6% yellow metal fall in Sept 2026? Will Diwali help bounce back? Experts view

At 52-week lows: RIL, ONGC, M&M, Airtel, PB Fintech, 69 other BSE500 stocks

Jacqueline Loh to step down as MAS deputy MD in senior leadership reshuffle

ShopeePay CEO on BNPL: why relying on late fees will fail